IT1406201B1 - Biomarcatori per la diagnosi della sclerosi multipla - Google Patents

Biomarcatori per la diagnosi della sclerosi multipla

Info

Publication number
IT1406201B1
IT1406201B1 ITPD2010A000374A ITPD20100374A IT1406201B1 IT 1406201 B1 IT1406201 B1 IT 1406201B1 IT PD2010A000374 A ITPD2010A000374 A IT PD2010A000374A IT PD20100374 A ITPD20100374 A IT PD20100374A IT 1406201 B1 IT1406201 B1 IT 1406201B1
Authority
IT
Italy
Prior art keywords
biomarcers
diagnosis
multiple sclerosis
sclerosis
Prior art date
Application number
ITPD2010A000374A
Other languages
English (en)
Inventor
Sara Bembich
Paolo Edomi
Andrea Cortini
Original Assignee
Univ Degli Studi Trieste
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Degli Studi Trieste filed Critical Univ Degli Studi Trieste
Priority to ITPD2010A000374A priority Critical patent/IT1406201B1/it
Priority to EP11807881.5A priority patent/EP2649093B1/en
Priority to PCT/EP2011/072440 priority patent/WO2012076722A1/en
Priority to US13/992,625 priority patent/US20130316919A1/en
Publication of ITPD20100374A1 publication Critical patent/ITPD20100374A1/it
Application granted granted Critical
Publication of IT1406201B1 publication Critical patent/IT1406201B1/it

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/285—Demyelinating diseases; Multipel sclerosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Rehabilitation Therapy (AREA)
  • Genetics & Genomics (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
ITPD2010A000374A 2010-12-10 2010-12-10 Biomarcatori per la diagnosi della sclerosi multipla IT1406201B1 (it)

Priority Applications (4)

Application Number Priority Date Filing Date Title
ITPD2010A000374A IT1406201B1 (it) 2010-12-10 2010-12-10 Biomarcatori per la diagnosi della sclerosi multipla
EP11807881.5A EP2649093B1 (en) 2010-12-10 2011-12-12 Biomarkers for the diagnosis of multiple sclerosis
PCT/EP2011/072440 WO2012076722A1 (en) 2010-12-10 2011-12-12 Biomarkers for the diagnosis of multiple sclerosis
US13/992,625 US20130316919A1 (en) 2010-12-10 2011-12-12 Biomarkers for the diagnosis of multiple sclerosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITPD2010A000374A IT1406201B1 (it) 2010-12-10 2010-12-10 Biomarcatori per la diagnosi della sclerosi multipla

Publications (2)

Publication Number Publication Date
ITPD20100374A1 ITPD20100374A1 (it) 2012-06-11
IT1406201B1 true IT1406201B1 (it) 2014-02-14

Family

ID=43737184

Family Applications (1)

Application Number Title Priority Date Filing Date
ITPD2010A000374A IT1406201B1 (it) 2010-12-10 2010-12-10 Biomarcatori per la diagnosi della sclerosi multipla

Country Status (4)

Country Link
US (1) US20130316919A1 (it)
EP (1) EP2649093B1 (it)
IT (1) IT1406201B1 (it)
WO (1) WO2012076722A1 (it)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020503345A (ja) 2016-12-29 2020-01-30 ユニバーシティ オブ マイアミ 肺におけるインフラマソーム活性及び炎症をモジュレートする方法
US11840565B2 (en) 2016-12-29 2023-12-12 University Of Miami Methods and compositions for treating virus-associated inflammation
RU2020113702A (ru) * 2017-09-20 2021-10-25 Юниверсити Оф Майами Способ детектирования белков инфламмасомы в качестве биомаркеров неврологических расстройств
EP3572813A1 (en) * 2018-05-22 2019-11-27 Centre National de la Recherche Scientifique Diagnosis mehod of multiple sclerosis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002079218A1 (en) * 2001-03-30 2002-10-10 Wyeth Methods for diagnosing and treating multiple sclerosis and compositions thereof
WO2004005486A2 (en) * 2002-07-10 2004-01-15 Exelixis, Inc. Mp21s as modifiers of the p21 pathway and methods of use

Also Published As

Publication number Publication date
WO2012076722A1 (en) 2012-06-14
EP2649093B1 (en) 2016-08-10
ITPD20100374A1 (it) 2012-06-11
US20130316919A1 (en) 2013-11-28
EP2649093A1 (en) 2013-10-16

Similar Documents

Publication Publication Date Title
SMT201600135B (it) Nuovi inibitori della s-nitrosoglutatione riduttasi
SMT201600370B (it) Complessi chelati di oligonucleotidi
DK2580243T3 (da) Antibodies against human cd38
FI20105825A (fi) Veriryhmästatuksen käyttö III
CO6960555A2 (es) Procedimiento de preparación de 5-fluoro-1h-pirazolopiridinas sustituidas
BR112012031203A2 (pt) disposição de dois segmentos de trilho
BR112014003878A2 (pt) síntese de r-bifenilalaninol
BR112013008864A2 (pt) análogos d ciclosporina
FR2961260B1 (fr) Architecture de turbomoteur non lubrifie
DE112011103919A5 (de) Endoskop
IT1403282B1 (it) Procedimento per la preparazione di linagliptin
BR112013014966A2 (pt) composto aricíclico contínuo
DK2590565T3 (da) Blodprøvetagning
ITMI20110669A1 (it) Procedimento per la determinazione di uno spazio
ITBS20100012A1 (it) Procedimento per la preparazione di fluazinam
IT1406201B1 (it) Biomarcatori per la diagnosi della sclerosi multipla
ZA201402437B (en) Diagnosis of tuberculosis
ZA201308101B (en) Diagnostic use of prosomatostatin
IT1400937B1 (it) Procedimento per ottenere propoli anallergica
FR2955473B1 (fr) Structure de presentoir
IT1402715B1 (it) Sonda di tastaggio
FR2956419B1 (fr) Elements de construction calorifuges
FR2967885B1 (fr) Laryngoscope amagnetique
BR112013007817A2 (pt) síntese aperfeiçoada de peretinoin
BR112013007818A2 (pt) síntese aperfeiçoada de peretinoin